233 related articles for article (PubMed ID: 30773806)
21. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Ortel TL
Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
[TBL] [Abstract][Full Text] [Related]
22. Outcomes after heparin-induced thrombocytopenia in patients with Propaten vascular grafts.
Kasirajan K
Ann Vasc Surg; 2012 Aug; 26(6):802-8. PubMed ID: 22717356
[TBL] [Abstract][Full Text] [Related]
23. [Complex management of type 2 heparin-induced thrombocytopenia in patients with major bleeding tendency: two case report].
Walle EM; Gleizes O; Chassin O; Legris N; Chanson N; Ract C; Bergis B; Werner M; Drouot S; Proulle V
Ann Biol Clin (Paris); 2020 Dec; 78(6):639-646. PubMed ID: 33258456
[TBL] [Abstract][Full Text] [Related]
24. Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.
Park BD; Kumar M; Nagalla S; De Simone N; Aster RH; Padmanabhan A; Sarode R; Rambally S
Transfus Apher Sci; 2018 Aug; 57(4):561-565. PubMed ID: 30244713
[TBL] [Abstract][Full Text] [Related]
25. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
[TBL] [Abstract][Full Text] [Related]
26. Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia.
Warkentin TE
Thromb Haemost; 2016 Oct; 116(5):813-822. PubMed ID: 27656712
[TBL] [Abstract][Full Text] [Related]
27. Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report.
Roberge G; Tritschler T; MacGillivray C; Dufresne L; Nagpal SK; Scarvelis D
J Thromb Thrombolysis; 2020 Oct; 50(3):674-677. PubMed ID: 32056070
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: Atypical clinical features with heparin-dependent platelet activating antibodies.
Okata T; Miyata S; Miyashita F; Maeda T; Toyoda K
Platelets; 2015; 26(6):602-7. PubMed ID: 25383922
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune Heparin-Induced Thrombocytopenia.
Warkentin TE
J Clin Med; 2023 Nov; 12(21):. PubMed ID: 37959386
[TBL] [Abstract][Full Text] [Related]
30. Successful Treatment of Severe Heparin-induced Thrombocytopenia with Intravenous Immunoglobulin, Platelet Transfusion and Rivaroxaban: A Case Report.
Huang H; Lin Y; Yao RX; He MQ; Lin XJ
Chin Med Sci J; 2019 Mar; 34(1):60-64. PubMed ID: 30961783
[TBL] [Abstract][Full Text] [Related]
31. Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.
Yarbrough PM; Varedi A; Walker A; Rondina MT
Ann Pharmacother; 2012 Nov; 46(11):e30. PubMed ID: 23073302
[TBL] [Abstract][Full Text] [Related]
32. Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection.
Shiuan E; Sharma D; Ely EW; Moodabagil N; Tillman BF
J Thromb Thrombolysis; 2022 Aug; 54(2):367-371. PubMed ID: 35763168
[TBL] [Abstract][Full Text] [Related]
33. Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
Bartholomew JR; Hursting MJ
J Thromb Thrombolysis; 2005 Jun; 19(3):183-8. PubMed ID: 16082605
[TBL] [Abstract][Full Text] [Related]
34. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.
Warkentin TE; Pai M; Sheppard JI; Schulman S; Spyropoulos AC; Eikelboom JW
J Thromb Haemost; 2011 Dec; 9(12):2389-96. PubMed ID: 21883878
[TBL] [Abstract][Full Text] [Related]
35. How we manage patients with heparin induced thrombocytopenia.
Scully M; Gates C; Neave L
Br J Haematol; 2016 Jul; 174(1):9-15. PubMed ID: 27097741
[TBL] [Abstract][Full Text] [Related]
36. A journey through anticoagulant therapies in the treatment of left ventricular thrombus in post-COVID-19 heparin-induced thrombocytopenia: a case report.
Lázaro-García A; Martínez-Alfonzo I; Vidal-Laso R; Velasco-Rodríguez D; Tomás-Mallebrera M; González-Rodríguez M; Llamas-Sillero P
Hematology; 2022 Dec; 27(1):318-321. PubMed ID: 35231200
[TBL] [Abstract][Full Text] [Related]
37. Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report.
Gonzales M; Pipalia A; Weil A
J Investig Med High Impact Case Rep; 2019; 7():2324709619832324. PubMed ID: 30939936
[TBL] [Abstract][Full Text] [Related]
38. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
[TBL] [Abstract][Full Text] [Related]
39. Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia.
Al-Eidan FAS; Alrawkan S; Alshammary H; Crowther MA
Ann Hematol; 2018 Nov; 97(11):2055-2059. PubMed ID: 30003318
[TBL] [Abstract][Full Text] [Related]
40. IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.
Padmanabhan A; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Bryant BJ; Alperin JB; Deloughery TG; Mulvey KP; Dhakal B; Wen R; Wang D; Aster RH
Chest; 2017 Sep; 152(3):478-485. PubMed ID: 28427966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
